<?xml version="1.0" encoding="UTF-8" ?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/pharmaceutical_report.shtml">
  <title>Market Research Reports for Pharmaceutical</title>
  <link>http://www.giiresearch.com/pharmaceutical_report.shtml</link>
  <description>Market Research Reports for Pharmaceutical</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2013 Global Information, Inc.</dc:rights>
  <dc:date>2013-05-17</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/acmc270035-china-pharmaceutical-guidebook-series-4-material.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224802-future-french-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224803-future-german-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224804-future-italian-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224805-future-japanese-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224806-future-spanish-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224807-future-uk-infectious-disease-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224808-future-us-infectious-disease-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs270651-analysis-north-american-oral-solid-drug-dosage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi189221-travel.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm270512-contraceptives-market-global-industry-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi270598-south-korea-pharmaceutical-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi270599-changing-regulatory-reimbursement-scenario-medical.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/acmc269863-china-pharmaceutical-guidebook-series-3-edition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc117624-infectious-disease.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs270472-chinese-pharmaceutical-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild117615-clinical-stage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mh165553-us-diseas-inci-prev.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jdi269967-otc-distribution-central-eastern-europes-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt233148-drug-delivery-technologies-commercial-prospects.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid81739-cn-autoimmune.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid81740-cn-mental-illness.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86318-ch-antibiotics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86341-ch-hypertension.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86346-ch-anti-obesity.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid91227-ch-blood-disease.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid100198-china-anti-tumor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid100219-china-central-nervous.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106808-ch-in-vitro-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106812-ch-smoking-cessation-aids.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106815-china-disinfectants.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid107511-ch-pneumonia-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg170733-facial-injectables.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/heal206822-notable-news-life-sciences-2q11.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd242636-partnerships-licensing-investments-m-deals-trends.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270217-opportunityanalyzer-idiopathic-pulmonary-fibrosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270218-opportunityanalyzer-cystic-fibrosis-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270219-pharmasphere-early-stage-technology-transfer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi269604-japan-pharmaceutical-market-outlook-deregulation.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/eo180624-us-consumer-health.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc180733-healthcare-information.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mama269095-drug-delivery-technologies-market-metered-dose.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mcd269546-early-stage-drug-delivery-technologies-profiles.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs269105-healthcare-landscape-outlook-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166029-breast-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166034-cancer-immunothera.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166070-colorectal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166071-hematologi-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166075-lymphoma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166078-peptides-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166079-prostate-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167148-androgen-recept.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167150-angiogene-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167165-bladder-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171731-brain-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171732-breast-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171733-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171735-cellular-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171737-colorectal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171746-gene-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171747-head-neck-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171749-hematological-cancers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171753-il-3-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171754-il-4-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171756-il-6-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171757-il-7-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171758-il-9-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171759-immunotherapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171761-kit-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171762-leukemia-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171763-liver-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171765-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171766-lymphoma-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171767-melanoma-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171769-notch-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171770-nucleic-acid.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171772-ovarian-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171783-peptides-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171784-prostate-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171785-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171786-proteins-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171788-radiation-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171789-renal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171790-rna-interference.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171794-wnt-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg191458-leukemia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235307-delirium-global-clinical-trials-review-h1-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235310-dystonia-global-clinical-trials-review-h1-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235311-anorexia-nervosa-global-clinical-trials-review-h1.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235312-dyskinesia-global-clinical-trials-review-h1-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235316-radiculopathy-global-clinical-trials-review-h1.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235317-diverticulitis-global-clinical-trials-review-h1.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer269004-competitor-analysis-g-csf-gm-csf.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei269015-medical-affairs-resource-allocation-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/acmc196754-material-clinical-trial-requirements-application.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt233147-needle-free-delivery-technology-market-2012-2022.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hui269576-research-investment-value-evaluation-on-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg233489-2012-european-infectious-disease-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166153-cea-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166336-rsv-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166337-rubella-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166338-salmonella-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166339-septicemia-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166340-shigella-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166341-streptococci-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166342-syphilis-diagno.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es268890-worldwide-guide-pricing-reimbursement.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid81742-cn-incretion-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86316-ch-alzheimer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106807-china-pediatric-drugs.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid269001-prescription-drugs-markets-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hui269573-research-investment-value-analysis-china-chemical.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235309-bronchospasm-global-clinical-trials-review-h1-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd235313-lennox-gastaut-syndrome-global-clinical-trials.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/acmc270035-china-pharmaceutical-guidebook-series-4-material.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-05-20</dc:date>
  <dc:creator>Access China Management Consulting</dc:creator>
  <title>China Pharmaceutical Guidebook Series (4) 2013 - Material &amp; Clinical Trial Requirements of Application &amp; Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines &amp; Natural Medicines</title>
  <link>http://www.giiresearch.com/report/acmc270035-china-pharmaceutical-guidebook-series-4-material.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224802-future-french-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224802-future-french-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224803-future-german-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224803-future-german-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224804-future-italian-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224804-future-italian-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224805-future-japanese-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224805-future-japanese-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224806-future-spanish-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224806-future-spanish-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224807-future-uk-infectious-disease-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224807-future-uk-infectious-disease-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224808-future-us-infectious-disease-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224808-future-us-infectious-disease-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs270651-analysis-north-american-oral-solid-drug-dosage.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-15</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Analysis of the North American Oral Solid Drug Dosage Excipients Market</title>
  <link>http://www.giiresearch.com/report/fs270651-analysis-north-american-oral-solid-drug-dosage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi189221-travel.html">
  <dc:language>en</dc:language>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth</title>
  <link>http://www.giiresearch.com/report/gbi189221-travel.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease</title>
  <link>http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm270512-contraceptives-market-global-industry-analysis.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Contraceptives Market - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018</title>
  <link>http://www.giiresearch.com/report/tsm270512-contraceptives-market-global-industry-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi270598-south-korea-pharmaceutical-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>South Korea Pharmaceutical Market Outlook 2013</title>
  <link>http://www.giiresearch.com/report/gbi270598-south-korea-pharmaceutical-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi270599-changing-regulatory-reimbursement-scenario-medical.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market</title>
  <link>http://www.giiresearch.com/report/gbi270599-changing-regulatory-reimbursement-scenario-medical.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Post-Patent Generic and Biosimilar Defense Strategies: Harnessing Competitive Tactics to Mitigate Revenue Erosion</title>
  <link>http://www.giiresearch.com/report/cei121988-generic-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>World Biological Drugs Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/acmc269863-china-pharmaceutical-guidebook-series-3-edition.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-05-10</dc:date>
  <dc:creator>Access China Management Consulting</dc:creator>
  <title>China Pharmaceutical Guidebook Series (3) 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products</title>
  <link>http://www.giiresearch.com/report/acmc269863-china-pharmaceutical-guidebook-series-3-edition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc117624-infectious-disease.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:date>2013-05-09</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Global Markets for Infectious Disease Treatments</title>
  <link>http://www.giiresearch.com/report/bc117624-infectious-disease.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs270472-chinese-pharmaceutical-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-05-09</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Chinese Pharmaceutical Market</title>
  <link>http://www.giiresearch.com/report/fs270472-chinese-pharmaceutical-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild117615-clinical-stage.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild117615-clinical-stage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Discovery Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Cancer Monoclonal Antibody Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Antibiotics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives</title>
  <link>http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mh165553-us-diseas-inci-prev.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-07</dc:date>
  <dc:creator>Medtech Insight</dc:creator>
  <title>U.S. Disease Incidence and Prevalence</title>
  <link>http://www.giiresearch.com/report/mh165553-us-diseas-inci-prev.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jdi269967-otc-distribution-central-eastern-europes-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:date>2013-05-06</dc:date>
  <dc:creator>James Dudley International, Ltd.</dc:creator>
  <title>OTC Distribution in Central and Eastern Europe's Growth MarketsGrasping the Opportunities in Russia, Ukraine, Poland, Romania and Bulgaria</title>
  <link>http://www.giiresearch.com/report/jdi269967-otc-distribution-central-eastern-europes-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt233148-drug-delivery-technologies-commercial-prospects.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-05-03</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Drug Delivery Technologies: Commercial Prospects 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt233148-drug-delivery-technologies-commercial-prospects.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid81739-cn-autoimmune.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Autoimmune Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid81739-cn-autoimmune.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid81740-cn-mental-illness.html">
  <dc:language>en</dc:language>
  <dc:subject>Mental Disease</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Mental Illness Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid81740-cn-mental-illness.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86318-ch-antibiotics.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Antibiotics Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86318-ch-antibiotics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Lymphoma Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86341-ch-hypertension.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Hypertension Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86341-ch-hypertension.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Osteoporosis Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86346-ch-anti-obesity.html">
  <dc:language>en</dc:language>
  <dc:subject>Obesity Treatment</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Anti-Obesity Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86346-ch-anti-obesity.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid91227-ch-blood-disease.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Blood Disease Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid91227-ch-blood-disease.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid100198-china-anti-tumor.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Anti-Tumor Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid100198-china-anti-tumor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid100219-china-central-nervous.html">
  <dc:language>en</dc:language>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Central Nervous System Disorder Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid100219-china-central-nervous.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106808-ch-in-vitro-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>In Vitro Diagnostics Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106808-ch-in-vitro-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Monoclonal Antibody Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106812-ch-smoking-cessation-aids.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Smoking Cessation Aids Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106812-ch-smoking-cessation-aids.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106815-china-disinfectants.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Disinfectants Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106815-china-disinfectants.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid107511-ch-pneumonia-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Pneumonia Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid107511-ch-pneumonia-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters &amp; Biosuperiors</title>
  <link>http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg170733-facial-injectables.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>Global Competitor Insights for Facial Injectables 2013</title>
  <link>http://www.giiresearch.com/report/mrg170733-facial-injectables.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cancer Diagnostic Testing World Markets</title>
  <link>http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>PMR</dc:creator>
  <title>Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and Kazakhstan: Development forecasts for 2013-2015</title>
  <link>http://www.giiresearch.com/report/pmr179466-generic-drug-russia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Biosimilars And Follow-On Biologics: World Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt204743-biosimilars-follow-on-biologics-world-market-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/heal206822-notable-news-life-sciences-2q11.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>IDC Health Insights</dc:creator>
  <title>Notable News in the Life Sciences: 1Q13</title>
  <link>http://www.giiresearch.com/report/heal206822-notable-news-life-sciences-2q11.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd242636-partnerships-licensing-investments-m-deals-trends.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Partnerships, Licensing, Investments and M&amp;A Deals and Trends in Pharmaceuticals - Q1 2013</title>
  <link>http://www.giiresearch.com/report/gd242636-partnerships-licensing-investments-m-deals-trends.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270217-opportunityanalyzer-idiopathic-pulmonary-fibrosis.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017</title>
  <link>http://www.giiresearch.com/report/gd270217-opportunityanalyzer-idiopathic-pulmonary-fibrosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270218-opportunityanalyzer-cystic-fibrosis-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017</title>
  <link>http://www.giiresearch.com/report/gd270218-opportunityanalyzer-cystic-fibrosis-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270219-pharmasphere-early-stage-technology-transfer.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies &amp; Deal Synergies between Academia and the Pharmaceutical Industry</title>
  <link>http://www.giiresearch.com/report/gd270219-pharmasphere-early-stage-technology-transfer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi269604-japan-pharmaceutical-market-outlook-deregulation.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-04-29</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players</title>
  <link>http://www.giiresearch.com/report/gbi269604-japan-pharmaceutical-market-outlook-deregulation.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/eo180624-us-consumer-health.html">
  <dc:language>en</dc:language>
  <dc:subject>OTC Drug</dc:subject>
  <dc:date>2013-04-26</dc:date>
  <dc:creator>Euromonitor International</dc:creator>
  <title>Consumer Health in the US</title>
  <link>http://www.giiresearch.com/report/eo180624-us-consumer-health.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc180733-healthcare-information.html">
  <dc:language>en</dc:language>
  <dc:subject>Healthcare IT</dc:subject>
  <dc:date>2013-04-25</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Healthcare Information Technology</title>
  <link>http://www.giiresearch.com/report/bc180733-healthcare-information.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mama269095-drug-delivery-technologies-market-metered-dose.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-24</dc:date>
  <dc:creator>Markets and Markets</dc:creator>
  <title>Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017</title>
  <link>http://www.giiresearch.com/report/mama269095-drug-delivery-technologies-market-metered-dose.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mcd269546-early-stage-drug-delivery-technologies-profiles.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-24</dc:date>
  <dc:creator>MCD Group, LLC</dc:creator>
  <title>Early Stage Drug Delivery Technologies: Profiles of Start-ups and Emerging Companies</title>
  <link>http://www.giiresearch.com/report/mcd269546-early-stage-drug-delivery-technologies-profiles.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs269105-healthcare-landscape-outlook-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-04-23</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Healthcare Landscape, Outlook, and Growth Opportunities in India</title>
  <link>http://www.giiresearch.com/report/fs269105-healthcare-landscape-outlook-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Antibodies and Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166029-breast-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Breast Cancer</title>
  <link>http://www.giiresearch.com/report/bg166029-breast-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166034-cancer-immunothera.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Immunotherapy</title>
  <link>http://www.giiresearch.com/report/bg166034-cancer-immunothera.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Therapeutic Antibodies</title>
  <link>http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166070-colorectal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Colorectal Cancer</title>
  <link>http://www.giiresearch.com/report/bg166070-colorectal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166071-hematologi-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Hematological Cancers</title>
  <link>http://www.giiresearch.com/report/bg166071-hematologi-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166075-lymphoma.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Lymphoma</title>
  <link>http://www.giiresearch.com/report/bg166075-lymphoma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Pancreatic Cancer</title>
  <link>http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166078-peptides-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166078-peptides-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166079-prostate-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Prostate Cancer</title>
  <link>http://www.giiresearch.com/report/bg166079-prostate-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Protein Kinase Inhibitors in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167148-androgen-recept.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167148-androgen-recept.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167150-angiogene-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Angiogenesis in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167150-angiogene-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Antibodies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Apoptosis in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167162-b-cell-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Biologicals in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167165-bladder-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Bladder Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167165-bladder-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171731-brain-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Brain Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171731-brain-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171732-breast-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Breast Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171732-breast-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171733-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Vaccines Drug Pipeline 2013</title>
  <link>http://www.giiresearch.com/report/bg171733-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171735-cellular-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cellular Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171735-cellular-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171737-colorectal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Colorectal Cancer Drug Pipeline 2013</title>
  <link>http://www.giiresearch.com/report/bg171737-colorectal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cytokine Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171744-cytokine-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171745-egfr1-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171746-gene-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Gene Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171746-gene-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171747-head-neck-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Head and Neck Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171747-head-neck-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171749-hematological-cancers.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Hematological Cancers Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171749-hematological-cancers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>ID Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171753-il-3-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171753-il-3-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171754-il-4-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171754-il-4-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171756-il-6-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171756-il-6-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171757-il-7-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171757-il-7-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171758-il-9-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171758-il-9-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171759-immunotherapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Immunotherapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171759-immunotherapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171761-kit-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171761-kit-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171762-leukemia-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Leukemia Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171762-leukemia-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171763-liver-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Liver Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171763-liver-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171765-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Lung Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171765-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171766-lymphoma-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Lymphoma Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171766-lymphoma-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171767-melanoma-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Melanoma Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171767-melanoma-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Neuroendocrine Tumors Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171769-notch-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Notch Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171769-notch-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171770-nucleic-acid.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Nucleic Acid Therapies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171770-nucleic-acid.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171772-ovarian-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Ovarian Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171772-ovarian-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Pancreatic Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171783-peptides-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Peptides in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171783-peptides-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171784-prostate-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Prostate Cancer Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171784-prostate-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171785-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171785-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171786-proteins-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Proteins in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171786-proteins-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171788-radiation-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Radiation Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171788-radiation-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171789-renal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Renal Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171789-renal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171790-rna-interference.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RNA Interference Therapy in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171790-rna-interference.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171794-wnt-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Wnt Signaling Pathway in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171794-wnt-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg191458-leukemia.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Leukemia</title>
  <link>http://www.giiresearch.com/report/bg191458-leukemia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Lung Cancer</title>
  <link>http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Apoptosis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Angiogenesis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Vaccines</title>
  <link>http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Melanoma</title>
  <link>http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>FSH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Leptin Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RANKL Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TSH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TSLP Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235307-delirium-global-clinical-trials-review-h1-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Delirium Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235307-delirium-global-clinical-trials-review-h1-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235310-dystonia-global-clinical-trials-review-h1-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Dystonia Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235310-dystonia-global-clinical-trials-review-h1-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235311-anorexia-nervosa-global-clinical-trials-review-h1.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Anorexia Nervosa Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235311-anorexia-nervosa-global-clinical-trials-review-h1.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235312-dyskinesia-global-clinical-trials-review-h1-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Dyskinesia Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235312-dyskinesia-global-clinical-trials-review-h1-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235316-radiculopathy-global-clinical-trials-review-h1.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Radiculopathy Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235316-radiculopathy-global-clinical-trials-review-h1.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235317-diverticulitis-global-clinical-trials-review-h1.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Diverticulitis Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235317-diverticulitis-global-clinical-trials-review-h1.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Stem Cells Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Epigenetic Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Adherens Junction Targeting in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Calcium Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cell Cycle Targeting in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Interfering With the ECM-Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Gap Junctions in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>GnRH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Jak-STAT Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Tight Junctions in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>VEGF Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RIG-I-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>p53 Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>ErbB Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Transcriptional Misregulation in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Viral Carcinogenesis Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer269004-competitor-analysis-g-csf-gm-csf.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: G-CSF and GM-CSF</title>
  <link>http://www.giiresearch.com/report/lmer269004-competitor-analysis-g-csf-gm-csf.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei269015-medical-affairs-resource-allocation-global.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Medical Affairs: Resource Allocation for the Global Marketplace</title>
  <link>http://www.giiresearch.com/report/cei269015-medical-affairs-resource-allocation-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/acmc196754-material-clinical-trial-requirements-application.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-20</dc:date>
  <dc:creator>Access China Management Consulting</dc:creator>
  <title>China Pharmaceutical Guidebook Series (2) 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Chemical Drugs</title>
  <link>http://www.giiresearch.com/report/acmc196754-material-clinical-trial-requirements-application.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Rheumatoid Arthritis (RA): World Drug Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt233147-needle-free-delivery-technology-market-2012-2022.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Needle-Free Delivery: Technology And Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt233147-needle-free-delivery-technology-market-2012-2022.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hui269576-research-investment-value-evaluation-on-china.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Huidian Research (Beijing BeiFuYuan Information Consulting Co., Ltd)</dc:creator>
  <title>Research and Investment Value Evaluation on China Hospital Industry, 2013-2017</title>
  <link>http://www.giiresearch.com/report/hui269576-research-investment-value-evaluation-on-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg233489-2012-european-infectious-disease-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Infectious Disease Testing Market: France, Germany, Italy, Spai UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg233489-2012-european-infectious-disease-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166153-cea-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the CEA Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166153-cea-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166336-rsv-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Respiratory Syncytial Virus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166336-rsv-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166337-rubella-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Rubella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166337-rubella-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166338-salmonella-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Salmonella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166338-salmonella-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166339-septicemia-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Septicemia Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166339-septicemia-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166340-shigella-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Shigella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166340-shigella-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166341-streptococci-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Streptococci Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japam - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166341-streptococci-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166342-syphilis-diagno.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Syphilis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166342-syphilis-diagno.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the CA Tumor Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es268890-worldwide-guide-pricing-reimbursement.html">
  <dc:language>en</dc:language>
  <dc:subject>Regulation</dc:subject>
  <dc:date>2013-04-16</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>The Worldwide Guide to Pricing &amp; Reimbursement</title>
  <link>http://www.giiresearch.com/report/es268890-worldwide-guide-pricing-reimbursement.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid81742-cn-incretion-drug.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Incretion Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid81742-cn-incretion-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86316-ch-alzheimer.html">
  <dc:language>en</dc:language>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Alzheimer Disease Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86316-ch-alzheimer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106807-china-pediatric-drugs.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Pediatric Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106807-china-pediatric-drugs.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid269001-prescription-drugs-markets-china.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Prescription Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid269001-prescription-drugs-markets-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hui269573-research-investment-value-analysis-china-chemical.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Huidian Research (Beijing BeiFuYuan Information Consulting Co., Ltd)</dc:creator>
  <title>Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017</title>
  <link>http://www.giiresearch.com/report/hui269573-research-investment-value-analysis-china-chemical.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235309-bronchospasm-global-clinical-trials-review-h1-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-12</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Bronchospasm Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235309-bronchospasm-global-clinical-trials-review-h1-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd235313-lennox-gastaut-syndrome-global-clinical-trials.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-12</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd235313-lennox-gastaut-syndrome-global-clinical-trials.html</link>
  <description></description>
</item>
</rdf:RDF>